Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation

Weber, 2012, Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects, Curr. Pharm. Des., 18, 209, 10.2174/138161212799040501 Steinman, 2001, Multiple sclerosis: a two-stage disease, Nat. Immunol., 2, 762, 10.1038/ni0901-762 Keegan, 2002, Multiple sclerosis, Annu. Rev. Med., 53, 285, 10.1146/annurev.med.53.082901.103909 Simmons, 2013, Modeling the heterogeneity of multiple sclerosis in animals, Trends Immunol., 34, 410, 10.1016/j.it.2013.04.006 Furlan, 2009, Animal models of multiple sclerosis, Methods Mol. Biol., 549, 157, 10.1007/978-1-60327-931-4_11 Weiner, 2004, Immunosuppressive treatment in multiple sclerosis, J. Neurol. Sci., 223, 1, 10.1016/j.jns.2004.04.013 Luz-Crawford, 2013, Mesenchymal stem cells generate a CD4+CD25+Foxp3+regulatory T cell population during the differentiation process of Th1 and Th17 cells, Stem Cell Res. Ther., 4, 65, 10.1186/scrt216 Bai, 2012, Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models, Nat. Neurosci., 15, 862, 10.1038/nn.3109 Watt, 2013, The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential, Br. Med. Bull., 108, 25, 10.1093/bmb/ldt031 Prockop, 2012, Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation, Mol. Ther., 20, 14, 10.1038/mt.2011.211 Sonobe, 2007, Chronological changes of CD4+ and CD8+ t cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis, Tohoku J. Exp. Med., 213, 329, 10.1620/tjem.213.329 Montero, 2004, Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies, J. Autoimmun., 23, 1, 10.1016/j.jaut.2004.05.001 Shimojima, 2016, Conditioned medium from the stem cells of human exfoliated deciduous teeth ameliorates experimental autoimmune encephalomyelitis, J. Immunol., 10.4049/jimmunol.1501457 Togha, 2016, Rapamycin augments immunomodulatory properties of bone marrow-derived mesenchymal stem cells in experimental autoimmune encephalomyelitis, Mol. Neurobiol., 54, 2445, 10.1007/s12035-016-9840-3 Zhang, 2014, Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model, PLoS One, 9 Su, 2015, Administration of embryonic stem cell-derived thymic epithelial progenitors expressing MOG induces antigen-specific tolerance and ameliorates experimental autoimmune encephalomyelitis, J. Autoimmun., 58, 36, 10.1016/j.jaut.2015.01.002 Kassis, 2008, Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis, Arch. Neurol., 65, 753, 10.1001/archneur.65.6.753 Wang, 2018, SPK1-transfected UCMSC has better therapeutic activity than UCMSC in the treatment of experimental autoimmune encephalomyelitis model of Multiple sclerosis, Sci. Rep., 8, 1756, 10.1038/s41598-018-19703-5 Shu, 2018, The beneficial effect of human amnion mesenchymal cells in inhibition of inflammation and induction of neuronal repair in EAE mice, J. Immunol. Res., 2018, 1, 10.1155/2018/5083797 O’Neill, 2006, IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE, J. Neuroimmunol., 178, 1, 10.1016/j.jneuroim.2006.05.030 Cui, 2018, A CD300c-Fc fusion protein inhibits t cell immunity, Front. Immunol., 9, 2657, 10.3389/fimmu.2018.02657 Dang, 2014, Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis, Autophagy, 10, 1301, 10.4161/auto.28771 Wynn, 2013, Macrophage biology in development, homeostasis and disease, Nature, 496, 445, 10.1038/nature12034 Deng, 2012, IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration, J. Immunol., 189, 3669, 10.4049/jimmunol.1103180 Jiang, 2012, IL‐33 attenuates EAE by suppressing IL‐17 and IFN‐γ production and inducing alternatively activated macrophages, Eur. J. Immunol., 42, 1804, 10.1002/eji.201141947 Wang, 2016, Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis, Int. J. Dev. Neurosci., 49, 60, 10.1016/j.ijdevneu.2016.01.005 Wang, 2014, Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis, Stem Cell Rep., 3, 115, 10.1016/j.stemcr.2014.04.020 Bravo, 2016, Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis, Stem Cell Res. Ther., 7, 43, 10.1186/s13287-016-0304-5 Bai, 2009, Human bone marrow-derived mesenchymal stem cells induce Th2-Polarized immune response and promote endogenous repair in animal models of multiple sclerosis, Glia, 57, 1192, 10.1002/glia.20841 Lutton, 2004, Multiple sclerosis: etiological mechanisms and future directions, Eur. Neurol., 229, 12 Wynn, 2004, A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow, Blood, 104, 2643, 10.1182/blood-2004-02-0526 Harting, 2009, Intravenous mesenchymal stem cell therapy for traumatic brain injury: laboratory investigation, J. Neurosurg., 110, 1189, 10.3171/2008.9.JNS08158 Lee, 2009, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6, Cell Stem Cell, 5, 54, 10.1016/j.stem.2009.05.003 Tierney, 2009, Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis, Immunol. Cell Biol., 87, 235, 10.1038/icb.2008.99 Liu, 2013, Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil, PLoS One, 8